Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: the Poliambulanza Preliminary Experience.

CONCLUSION: In our study, the scalp-cooling device reduced chemotherapy-induced alopecia in taxane-based chemotherapy. Furthermore, it suggests a discordance in hair loss perception between patients and operators.
PMID: 30457055 [PubMed - as supplied by publisher]

Source: Reviews on Recent Clinical Trials - November 19, 2018 Category: Cancer & Oncology Authors: Prochilo T, Huscher A, Andreis F, Mirandola M, Zaina E, Pomentale B, Pedrali C, Zanotti L, Mutti S, Zaniboni A Tags: Rev Recent Clin Trials Source Type: research